Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS). British Journal of Surgery. 2003; 90:1200-1212
Adams RA, Meade AM, Madi A, Fisher D, Kay E, Kenny S, Kaplan RS, Maughan TS.
Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience. British Journal of Cancer. 2009; 100:251-258
Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE.
Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. Journal of Clinical Oncology. 2009; 27:5062-5067
Adams RA, Meade AM, Seymour MT, Wilson RH, Madi A, Fisher D, Kenny SL, Kay E, Hodgkinson E, Pope M, Rogers P, Wasan H, Falk S, Gollins S, Hickish T, Bessell EM, Propper D, Kennedy MJ, Kaplan R, Maughan TS.
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet Oncology. 2011; 12:642-653
Asboe D, Goodall RL, Hooker M, Babiker AG, Darbyshire JH, William IA.
A virological benefit from an induction/maintenance strategy: the Forte trial. Antiviral Therapy. 2007; 12:47-54
Angus B, Lampe F, Tambussi G, Duvivier C, Katlama C, Youle M, Williams I, Clotet B, Fisher M, Post FA, Babiker A, Phillips A, TILT Trial Steering Committee.
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals. AIDS. 2008; 22:737-740
Arenas-Pinto A, Bhaskaran K, Dunn D, Weller IV.
The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antiviral Therapy. 2008; 13:289-295
Achhra AC, Amin J, Law MG, Emery S, Gerstoft J, Gordin FM, Vjecha MJ, Neaton JD, Cooper DA, for INSIGHT ESPRIT & SILCAAT Study Groups.
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS. 2010; 24:1877-1886
Abel RM, Doré CJ, Bishop AE, Facer P, Polak JM, Spitz L.
A histological study of the hph-1 mouse mutant: an animal model of phenylketonuria and infantile hypertrophic pyloric stenosis. Anatomia, Histologia, Embryologia. 2004; 33:125-130
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.
Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet. 2003; 361:1927-1934